Correlation between clinical response to sorafenib in hepatocellular carcinoma treatment and polymorphisms of P-glycoprotein (ABCB1) and of breast cancer resistance protein (ABCG2): monocentric study-Reference-Cited by-同舟云学术

Correlation between clinical response to sorafenib in hepatocellular carcinoma treatment and polymorphisms of P-glycoprotein (ABCB1) and of breast cancer resistance protein (ABCG2): monocentric study

Published:2017-03-13 Issue:4 Volume:79 Page:759-766
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Tandia Mahamadou,Mhiri Asma,Paule Bernard,Saffroy Raphaël,Cailliez Valérie,Noé Gaëlle,Farinotti Robert,Bonhomme-Faivre Laurence

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-017-3268-y.pdf

Reference24 articles.

1. McGlynn KA, Petrick JL, London WT (2015) Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability. Clin Liver Dis 19(2):223–238

2. Maillard E (2011) Epidémiologie, histoire naturelle et pathogenèse du carcinome hépatocellulaire. Cancer/radiothérapie 15(1):3–6

3. Yang HI, Yeh SH, Chen PJ, Iloeje UH, Jen CL, Su J et al (2008) Associations between Hepatitis B Virus genotype and mutants and the risk of hepatocellular carcinoma. J Natl cancer Inst 100:1134–1143

4. Bruno S, Crasignani A, Maisonneuve P, Rossi S, Sitini E, Mandelli MU (2007) Hepatitis C Virus genotype 1b as a major risk factor associated with hepatocellular carcinoma on patients with cirrhosis: a seventeen-year prospective cohort study. Hepatology 46:1350–1356

5. Fattovich G, Stroffolini T, Zagni I, Danata F (2004) Hepatocellular carcinoma in cirrhosis: incidence and risk factor. Gastroenterology 127(5):35–50

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacology of Tyrosine Kinase Inhibitors;Clinical Journal of the American Society of Nephrology;2023-12-11

2. Analysis of prognostic germline polymorphisms in patients with advanced hepatocellular carcinoma;Translational Gastroenterology and Hepatology;2023-10

3. The impact of ABCB1, CYP3A4/5 and ABCG2 gene polymorphisms on rivaroxaban trough concentrations and bleeding events in patients with non-valvular atrial fibrillation;Human Genomics;2023-07-07

4. Cannabis Pharmacogenomics: A Path to Personalized Medicine;Current Issues in Molecular Biology;2023-04-17

5. The critical role of circular RNAs in drug resistance in gastrointestinal cancers;Medical Oncology;2023-03-14